Once again less than 2% of the float was traded today. I haven’t seen anyone but flippers and shorts state that they sold or are worried about others selling because this is recycled old news. The last proactive video stated best from DR Scott Kelly that Cytodyn has never been better positioned. That is from an operational stand point and financial standpoint. Huge distribution agreements and there foot is in the door in some of the largest population countries in the world and that’s for all future indications. Stock price fair value should be between $12-$15 right now in my opinion. There are tons of pre revenue companies in that range with far far less to offer.